Cargando…

Positive expression of ZNF689 indicates poor prognosis of hepatocellular carcinoma

The objective of the present study was to investigate the association between zinc finger protein (ZNF) 689 expression and the clinicopathological features and prognosis of hepatocellular carcinoma (HCC). A total of 102 paired HCC and paired non-cancerous tissues, and 16 normal liver tissues were co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yi, Peng Sheng, Wu, Bin, Deng, Da Wei, Zhang, Guang Nian, Li, Jian Shui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144284/ https://www.ncbi.nlm.nih.gov/pubmed/30250580 http://dx.doi.org/10.3892/ol.2018.9295

Ejemplares similares

MicroRNA-339 inhibits human hepatocellular carcinoma proliferation and invasion via targeting ZNF689
por: Zeng, Hui, et al.
Publicado: (2019)

MiRNA-339 targets and regulates ZNF689 to inhibit the proliferation and invasion of gastric cancer cells
por: Jiang, Houxiang, et al.
Publicado: (2021)

High expression of miR-21 is not a predictor of poor prognosis in all patients with hepatocellular carcinoma
por: Yi, Peng Sheng, et al.
Publicado: (2018)

Overexpression of SCAMP3 is an indicator of poor prognosis in hepatocellular carcinoma
por: Zhang, Xinyuan, et al.
Publicado: (2017)

CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients
por: Yao, Yang, et al.
Publicado: (2019)

Decrease of Fibulin-3 in Hepatocellular Carcinoma Indicates Poor Prognosis
por: Luo, Rongzhen, et al.
Publicado: (2013)

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
por: Tian, Yunhong, et al.
Publicado: (2018)

Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma
por: Lei, Xiong, et al.
Publicado: (2015)

Down-regulation of RBP4 indicates a poor prognosis and correlates with immune cell infiltration in hepatocellular carcinoma
por: Li, Mingxing, et al.
Publicado: (2021)

ZNF385A and ZNF346 Serve as Prognostic Biomarkers Associated with an Inflamed Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma
por: Peng, Qihang, et al.
Publicado: (2023)

Sperm-Associated Antigen 5 Expression Is Increased in Hepatocellular Carcinoma and Indicates Poor Prognosis
por: Zhou, Hua, et al.
Publicado: (2018)

High USP22 expression indicates poor prognosis in hepatocellular carcinoma
por: Tang, Bo, et al.
Publicado: (2015)

Increased Expression of CAP2 Indicates Poor Prognosis in Hepatocellular Carcinoma()()
por: Fu, Jia, et al.
Publicado: (2015)

Linc00511 Indicates A Poor Prognosis Of Liver Hepatocellular Carcinoma
por: Hu, Pingan, et al.
Publicado: (2019)

Decrease of RBM4 indicates poor prognosis in patients with hepatocellular carcinoma after hepatectomy
por: Chen, Jian-yao, et al.
Publicado: (2017)

Numb Promotes Cell Proliferation and Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Wu, Jian, et al.
Publicado: (2014)

High expression of GNA13 is associated with poor prognosis in hepatocellular carcinoma
por: Xu, Yi, et al.
Publicado: (2016)

MON-689 Diabetes Mellitus---Hypoglycemic Response---Empyema
por: Chen, Yaning
Publicado: (2020)

Low Expression of ZNF154 is Related to Poor Prognosis in Gastric Cancer
por: He, Jinsong, et al.
Publicado: (2022)

PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma
por: Liu, Wei-Ren, et al.
Publicado: (2014)

Alternatively activated NUSAP1 promotes tumor growth and indicates poor prognosis in hepatocellular carcinoma
por: Shi, Chao, et al.
Publicado: (2019)

MMP16 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma
por: Shen, Zhenghai, et al.
Publicado: (2017)

LCMT1 indicates poor prognosis and is essential for cell proliferation in hepatocellular carcinoma
por: Zhang, Ning, et al.
Publicado: (2022)

Correction: Numb Promotes Cell Proliferation and Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Wu, Jian, et al.
Publicado: (2022)

LincRNA ZNF529-AS1 inhibits hepatocellular carcinoma via FBXO31 and predicts the prognosis of hepatocellular carcinoma patients
por: Ma, Yang, et al.
Publicado: (2023)

Increased expression of G9A contributes to carcinogenesis and indicates poor prognosis in hepatocellular carcinoma
por: Qin, Jian, et al.
Publicado: (2018)

Embryonic Morphogen Nodal Is Associated with Progression and Poor Prognosis of Hepatocellular Carcinoma
por: Chen, Jing, et al.
Publicado: (2014)

Elevated Serum S100A9 Indicated Poor Prognosis in Hepatocellular Carcinoma after Curative Resection
por: Meng, Jun, et al.
Publicado: (2019)

689. Streptococcus suis Endocarditis: Echocardiographic Features and Clinical Outcomes
por: Trirattanapa, Kornkanok, et al.
Publicado: (2021)

Increased expression of protease-activated receptors 2 indicates poor prognosis in HBV related hepatocellular carcinoma
por: Chen, Peng, et al.
Publicado: (2019)

RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma
por: Wang, Wei, et al.
Publicado: (2017)

CELSR3 mRNA expression is increased in hepatocellular carcinoma and indicates poor prognosis
por: Gu, Xuefeng, et al.
Publicado: (2019)

MicroRNA-497-5p Is Downregulated in Hepatocellular Carcinoma and Associated with Tumorigenesis and Poor Prognosis in Patients
por: Tian, Lin-Lin, et al.
Publicado: (2021)

Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma
por: ZHANG, ZHEN-HAI, et al.
Publicado: (2014)

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma
por: Jiang, Shan-Shan, et al.
Publicado: (2014)

Screening of significant biomarkers with poor prognosis in hepatocellular carcinoma via bioinformatics analysis
por: Sun, Quanquan, et al.
Publicado: (2020)

Co-expression of Piwil2/Piwil4 in nucleus indicates poor prognosis of hepatocellular carcinoma
por: Zeng, Guangping, et al.
Publicado: (2016)

High expression levels of CLEC4M indicate poor prognosis in patients with hepatocellular carcinoma
por: Luo, Liuping, et al.
Publicado: (2020)

High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma
por: Wang, Xuequan, et al.
Publicado: (2022)

PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis
por: Du, Peng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ndil0io483i44s2kpe7veeud07